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Introduction
Mesenchymal stromal cells (MSC) are multipotent cells
with an immune suppressive capacity. In the last decade
the therapeutic application of these cells has been tested
in inflammatory diseases like graft versus host disease
and rheumatoid arthritis. Injection of MSC can be a
potential therapy for juvenile idiopathic arthritis patients
refractory to conventional therapies.
Objectives
We tested the mechanisms of MSC immune modulation
with a specific focus on the suppression of synovial fluid
derived immune cells.
Methods
We setup an in vitro culture system to test the suppressive
capacity of MSC on both peripheral blood cells (PBMC)
and synovial fluid cells (SFMC). We tested T cell prolifera-
tion and cytokine production of healthy controls and JIA
patients. Furthermore, we investigated the induction or
suppression of regulatory T cells (Treg) and Th17 cells as
these cells have an important role in JIA pathogenesis and
tested the effect of inflammatory cytokines and monocytes
on MSC suppression.
Results
MSC dose dependently suppressed both PBMC and
SFMC, but SF T cells were less receptive towards MSC
suppression. Tnfa and ifng were suppressed in both
PBMC and SFMC, but IL-17 was not affected. In
PBMC, but not SFMC, Th17 cell numbers were reduced
by MSC and Treg numbers increased. We found no
clear role for monocytes or inflammatory cytokines tnfa
and ifng in activating the immune suppressive activity of
MSC as published before.
Conclusion
We conclude that MSC can suppress T cells derived
from JIA synovial fluid. However, this suppression is
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